NCT03386279View on ClinicalTrials.gov

A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and Moxifloxacin

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

PF-04965842

one single dose of 600 mg by mouth

DRUG

Moxifloxacin

one single dose of 400 mg by mouth

DRUG

Placebo

one single dose by mouth

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY